| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.56B | 52.60B | 56.22B | 49.72B | 58.19B | 40.81B |
| Gross Profit | 7.31B | 7.16B | 7.22B | 6.72B | 6.72B | 5.95B |
| EBITDA | 10.11B | 9.92B | 9.59B | 9.05B | 8.91B | 7.98B |
| Net Income | 5.89B | 5.81B | 5.90B | 5.53B | 5.49B | 4.64B |
Balance Sheet | ||||||
| Total Assets | 80.64B | 77.90B | 77.17B | 70.98B | 68.11B | 67.53B |
| Cash, Cash Equivalents and Short-Term Investments | 1.39B | 1.68B | 583.00M | 180.00M | 76.00M | 2.82B |
| Total Debt | 34.42B | 34.93B | 32.26B | 29.07B | 28.64B | 29.87B |
| Total Liabilities | 50.29B | 47.41B | 47.58B | 42.22B | 40.41B | 41.09B |
| Stockholders Equity | 29.53B | 29.74B | 28.73B | 27.67B | 26.62B | 25.33B |
Cash Flow | ||||||
| Free Cash Flow | 2.20B | 2.96B | 3.57B | 4.30B | 6.08B | 6.29B |
| Operating Cash Flow | 7.74B | 8.59B | 8.12B | 7.57B | 8.04B | 8.51B |
| Investing Cash Flow | -4.83B | -5.49B | -5.43B | -3.20B | -4.95B | -2.13B |
| Financing Cash Flow | -2.98B | -2.69B | -2.16B | -4.26B | -5.84B | -4.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $74.82B | 19.11 | 10.69% | 4.27% | 12.38% | 28.17% | |
73 Outperform | $84.87B | 13.95 | 20.04% | 6.72% | -9.49% | 1.01% | |
73 Outperform | $69.34B | 13.25 | 13.97% | 8.04% | 12.46% | -10.48% | |
73 Outperform | $55.58B | 15.91 | 33.27% | 7.31% | 3.18% | 6.43% | |
72 Outperform | $58.16B | 18.41 | 15.92% | 5.61% | 41.04% | 9.18% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | $95.05B | 24.40 | 22.37% | 3.35% | 9.99% | 22.02% |